Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry

N. A.G. Lankheet*, M. J.X. Hillebrand, H. Rosing, J. H.M. Schellens, J. H. Beijnen, A. D.R. Huitema

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

65 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry'. Together they form a unique fingerprint.

Chemistry

Veterinary Science and Veterinary Medicine

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Chemical Engineering